CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 20 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integrity Capital Management (HK) Ltd | 69,724 | $20,000 | 0.06% |
| Privium Fund Management B.V. | 163,030 | $42,000 | 0.01% |
| LMR Partners LLP | 229,750 | $558,000 | 0.01% |
| CVI Holdings, LLC | 264,407 | $77,000 | 0.01% |
| Yakira Capital Management, Inc. | 127,497 | $37,000 | 0.01% |
| Telemetry Investments, L.L.C. | 15,156 | $4,000 | 0.01% |
| Bulldog Investors, LLP | 43,258 | $12,000 | 0.00% |
| Context Capital Management, LLC | 87,175 | $25,000 | 0.00% |
| Warberg Asset Management LLC | 32,502 | $9,000 | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 66,986 | $19,000 | 0.00% |